Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 161,700 | 132,300 | 103,700 | 15,400 | 89,200 |
| Receivables | 942,300 | 993,800 | 899,000 | 845,100 | 884,400 |
| Inventories | 869,000 | 869,800 | 860,900 | 835,800 | 828,000 |
| Other current assets | 281,300 | 272,100 | 228,900 | 206,800 | 224,400 |
| TOTAL | $2,254,300 | $2,268,000 | $2,092,500 | $1,903,100 | $2,026,000 |
| Non-Current Assets | |||||
| PPE Net | 1,191,000 | 1,184,900 | 1,173,100 | 1,189,600 | 1,184,900 |
| Investments And Advances | 0 | 0 | 0 | 76,000 | 0 |
| Intangibles | 2,400,700 | 2,386,900 | 2,334,000 | 2,332,700 | 2,336,500 |
| Other Non-Current Assets | 398,400 | 404,100 | 393,900 | 320,800 | 411,600 |
| TOTAL | $3,990,100 | $3,975,900 | $3,901,000 | $3,919,100 | $3,933,000 |
| Total Assets | $6,244,400 | $6,243,900 | $5,993,500 | $5,822,200 | $5,959,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,600 | 132,600 | 132,600 | 132,900 | 1,100 |
| Accounts payable and accrued liabilities | 278,500 | 279,900 | 275,200 | 268,200 | 265,600 |
| Accrued Expenses | 703,800 | 597,600 | 519,100 | 606,500 | 673,000 |
| Other current liabilities | N/A | N/A | N/A | 29,100 | N/A |
| TOTAL | $1,777,300 | $1,813,600 | $1,686,100 | $1,514,700 | $1,584,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 841,500 | 841,500 | 841,700 | 841,700 | 974,400 |
| aiOther Non-Current Liabilities | 932,900 | 948,100 | 959,000 | 881,300 | 771,400 |
| TOTAL | $1,954,400 | $1,976,400 | $1,994,200 | $1,994,300 | $2,018,500 |
| Total Liabilities | $3,731,700 | $3,790,000 | $3,680,300 | $3,509,000 | $3,603,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 145,870 | 145,241 | 145,319 | 146,618 | 149,252 |
| Common Shares | 717,400 | 717,400 | 717,400 | 717,400 | 717,400 |
| Retained earnings | 4,785,500 | 4,727,000 | 4,589,700 | 4,529,900 | 4,398,400 |
| Other shareholders' equity | -133,200 | -125,400 | -157,900 | -170,100 | -113,200 |
| TOTAL | $2,512,700 | $2,453,900 | $2,313,200 | $2,313,200 | $2,355,600 |
| Total Liabilities And Equity | $6,244,400 | $6,243,900 | $5,993,500 | $5,822,200 | $5,959,000 |